Zhou Yiming worked as President and Chief Biomedical Information Officer of the Transforming Bioinformatics Institute of CapitalBio Corporation.

Zhou graduated from Tsinghua University and studied with Professor Cheng Jing, an academician of the Chinese Academy of Engineering and founder of CapitalBio. He has worked and studied at New York University, Arkansas Medical University, Harvard University, and MIT. Zhou founded Digomics LLC in the United States the clients of which include the University of California, FDA, Tsinghua University, and CapitalBio. Many of Zhou's papers were published in the world’s top scientific journals, such as Nature, Nature Biotechnology, Nature Cell Biology, PNAS, and Blood. He is also the chief scientist of a biomedical big data project of the National Hi-Tech Research and Development Program of China (863 Program).